The technology holds enormous opportunity but has failed to...

The technology holds enormous opportunity but has failed to really get moving over recent times. CSIRO have held onto their rights while seeking commercial partners. Company was/is as good as broke but the technology could be VERY attractive to one of the major drug companies. Should a major value it then looks very cheap.

Point is, that on todays announcement there is no reason for such aggressive buying unless there is an interested party. Look where it opened at 9.5/10cents ie. virtually unchanged......